TriSalus Life Sciences (TLSI) Other Non-Current Assets (2022 - 2026)
TriSalus Life Sciences posted quarterly Other Non-Current Assets of $69000.0 for Q1 2026, down 83.73% year-on-year from $424000.0 in Q1 2025, and down 83.49% on a QoQ basis from $418000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) has 5 years of Other Non-Current Assets data on file, last reported at $69000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 83.73% year-over-year to $69000.0; the trailing twelve-month figure through Mar 2026 stood at $69000.0 (down 83.73% YoY), and the FY2025 full-year result was $418000.0, down 1.18% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $69000.0, down from $418000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $466000.0 in Q4 2023 and bottomed at $69000.0 in Q1 2026.
- The 5-year median for Other Non-Current Assets is $421000.0 (2024), against an average of $387000.0.
- The widest annual swing landed in 2023, when Other Non-Current Assets advanced 26.98%; it then plunged 83.73% in 2026.
- A 5-year view of Other Non-Current Assets shows it stood at $367000.0 in 2022, then gained by 26.98% to $466000.0 in 2023, then slipped by 9.23% to $423000.0 in 2024, then slipped by 1.18% to $418000.0 in 2025, then plunged by 83.49% to $69000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $69000.0 (Q1 2026), $418000.0 (Q4 2025), and $419000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 419,000.00 |
| Mar 31, 2025 | 424,000.00 |
| Dec 31, 2024 | 423,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 424,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Dec 31, 2022 | 367,000.00 |